title: Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.
abstract: Cigarette smoke (CS) is a main risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress induced by CS causes DNA and lung damage. Oxidant/antioxidant imbalance occurs in the distal air spaces of smokers and in patients with COPD. We studied the effect of oxidative stress generated by CS both in vivo and in vitro on murine primary alveolar type II (ATII) cells isolated from nuclear erythroid 2-related factor-2 (Nrf2)(-/-) mice. We determined human primary ATII cell injury by CS in vitro and analyzed ATII cells isolated from smoker and non-smoker lung donors ex vivo. We also studied whether trolox (water-soluble derivative of vitamin E) could protect murine and human ATII cells against CS-induced DNA damage and/or decrease injury. We analyzed oxidative stress by 4-hydroxynonenal expression, reactive oxygen species (ROS) generation by Amplex Red Hydrogen Peroxide Assay, Nrf2, heme oxygenase 1, p53 and P53-binding protein 1 (53BP1) expression by immonoblotting, Nrf2 nuclear translocation, Nrf2 and p53 DNA-binding activities, apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay and cytokine production by ELISA. We found that ATII cells isolated from Nrf2(-/-) mice are more susceptible to CS-induced oxidative DNA damage mediated by p53/53BP1 both in vivo and in vitro compared with wild-type mice. Therefore, Nrf2 activation is a key factor to protect ATII cells against injury by CS. Moreover, trolox abolished human ATII cell injury and decreased DNA damage induced by CS in vitro. Furthermore, we found higher inflammation and p53 mRNA expression by RT-PCR in ATII cells isolated from smoker lung donors in comparison with non-smokers ex vivo. Our results indicate that the Nrf2 and p53 cross talk in ATII cells affect the susceptibility of these cells to injury by CS. Trolox can protect against oxidative stress, genotoxicity and inflammation induced by CS through ROS scavenging mechanism, and serve as a potential antioxidant prevention strategy against oxidative injury of ATII cells in CS-related lung diseases.
authors.affiliation: Department of Medicine, National Jewish Health, Denver, CO 80206, USA.
authors.forename: E M
authors.initials: EM
authors.lastname: Messier
authors.forename: K
authors.initials: K
authors.lastname: Bahmed
authors.forename: R M
authors.initials: RM
authors.lastname: Tuder
authors.forename: H W
authors.initials: HW
authors.lastname: Chu
authors.forename: R P
authors.initials: RP
authors.lastname: Bowler
authors.forename: B
authors.initials: B
authors.lastname: Kosmider
mesh_terms: D000447:Aldehydes / Q000378:metabolism; D056809:Alveolar Epithelial Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002839:Chromans / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D051267:NF-E2-Related Factor 2 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D018384:Oxidative Stress; D011650:Pulmonary Alveoli / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D012906:Smoke / Q000009:adverse effects; D012907:Smoking / Q000009:adverse effects; D014026:Nicotiana / Q000633:toxicity*; D016159:Tumor Suppressor Protein p53 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D000071857:Tumor Suppressor p53-Binding Protein 1
chemical_list: D000447:Aldehydes; D000975:Antioxidants; D002839:Chromans; D047908:Intracellular Signaling Peptides and Proteins; D051267:NF-E2-Related Factor 2; C495636:Nfe2l2 protein, mouse; D017382:Reactive Oxygen Species; D012906:Smoke; C498301:TP53BP1 protein, human; D016159:Tumor Suppressor Protein p53; D000071857:Tumor Suppressor p53-Binding Protein 1; D051547:Heme Oxygenase-1; C027576:4-hydroxy-2-nonenal; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
references.citation: Free Radic Biol Med. 2012 Sep 15;53(6):1279-85
references.pmid: 22841759
references.citation: Acta Biol Hung. 2006 Dec;57(4):403-13
references.pmid: 17278702
references.citation: BMC Biochem. 2001;2:14
references.pmid: 11734073
references.citation: Free Radic Res. 2010 Nov;44(11):1296-303
references.pmid: 20815775
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1211-8
references.pmid: 17209140
references.citation: Mutat Res. 2004 Sep 12;563(1):61-70
references.pmid: 15324749
references.citation: Am J Respir Cell Mol Biol. 2001 Mar;24(3):295-303
references.pmid: 11245628
references.citation: Arch Biochem Biophys. 2011 Mar 15;507(2):356-64
references.pmid: 21211512
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):250-5
references.pmid: 19104057
references.citation: Am J Respir Cell Mol Biol. 2007 Jun;36(6):661-8
references.pmid: 17255555
references.citation: J Neurosci Res. 2008 Dec;86(16):3584-604
references.pmid: 18655197
references.citation: Mol Cell Biol. 2003 Dec;23(23):8576-85
references.pmid: 14612402
references.citation: Lancet. 1999 Aug 7;354(9177):482-3
references.pmid: 10465176
references.citation: Oncol Rep. 2012 Dec;28(6):1959-67
references.pmid: 23023193
references.citation: Carcinogenesis. 1999 Aug;20(8):1491-7
references.pmid: 10426797
references.citation: Proc Am Thorac Soc. 2006 Aug;3(6):503-10
references.pmid: 16921129
references.citation: Thorax. 2000 Mar;55(3):189-93
references.pmid: 10679536
references.citation: Mol Cell Biol. 2003 Apr;23(7):2556-63
references.pmid: 12640136
references.citation: COPD. 2011 Aug;8(4):264-9
references.pmid: 21627570
references.citation: Exp Lung Res. 2012 Sep;38(7):363-73
references.pmid: 22888851
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2009 Aug;29(4):466-9
references.pmid: 19662364
references.citation: Oncotarget. 2012 Nov;3(11):1272-83
references.pmid: 23174755
references.citation: Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
references.pmid: 9240432
references.citation: DNA Repair (Amst). 2011 Oct 10;10(10):1071-6
references.pmid: 21868291
references.citation: Expert Opin Drug Deliv. 2011 Sep;8(9):1205-20
references.pmid: 21615218
references.citation: Int J Biol Sci. 2011;7(7):927-36
references.pmid: 21850202
references.citation: Int J Vitam Nutr Res. 2007 Jul;77(4):272-9
references.pmid: 18271282
references.citation: Carcinogenesis. 2004 Feb;25(2):169-78
references.pmid: 14578158
references.citation: Life Sci. 2004 Jun 4;75(3):271-86
references.pmid: 15135649
references.citation: Biochem Biophys Res Commun. 2011 Mar 11;406(2):292-8
references.pmid: 21320471
references.citation: J Toxicol Environ Health B Crit Rev. 2009 Jan;12(1):45-64
references.pmid: 19117209
references.citation: Neuropharmacology. 2012 Mar;62(4):1659-70
references.pmid: 22146407
references.citation: Carcinogenesis. 2005 Mar;26(3):605-12
references.pmid: 15579485
references.citation: Respir Res. 2012 Jun 06;13:43
references.pmid: 22672594
references.citation: Mol Med. 2001 Feb;7(2):135-45
references.pmid: 11471548
references.citation: Biochim Biophys Acta. 2002 Jun 13;1583(1):91-8
references.pmid: 12069853
references.citation: Toxicol Sci. 2000 Mar;54(1):104-9
references.pmid: 10746937
references.citation: Oncol Rep. 2010 Aug;24(2):321-8
references.pmid: 20596616
references.citation: Free Radic Biol Med. 2010 Jun 1;48(11):1513-24
references.pmid: 20219673
references.citation: J Biol Chem. 2006 Dec 29;281(52):39776-84
references.pmid: 17077087
references.citation: Curr Pharm Des. 2008;14(5):429-42
references.pmid: 18289070
references.citation: Antioxid Redox Signal. 2006 Jan-Feb;8(1-2):76-87
references.pmid: 16487040
references.citation: PLoS One. 2011;6(12):e26059
references.pmid: 22163265
references.citation: Toxicology. 2002 Jan 25;170(3):173-85
references.pmid: 11788155
references.citation: Toxicol Appl Pharmacol. 2010 Apr 1;244(1):43-56
references.pmid: 19646463
references.citation: Mutat Res. 2004 Mar 14;558(1-2):169-79
references.pmid: 15036130
references.citation: Nutrition. 2006 Nov-Dec;22(11-12):1192-201
references.pmid: 17095405
references.citation: Can J Cardiol. 1993 Jan-Feb;9(1):89-93
references.pmid: 8439833
references.citation: Am J Clin Nutr. 2001 Apr;73(4):673-86
references.pmid: 11273841
references.citation: J Appl Physiol (1985). 2008 Oct;105(4):1282-90
references.pmid: 18669934
references.citation: Respir Res. 2005 Jul 18;6:73
references.pmid: 16026622
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G286-98
references.pmid: 15194561
references.citation: J Biol Chem. 2003 Mar 7;278(10):8135-45
references.pmid: 12506115
references.citation: Thorax. 2011 Apr;66(4):320-5
references.pmid: 21257986
references.citation: Arch Biochem Biophys. 2004 Nov 1;431(1):138-44
references.pmid: 15464736
references.citation: Indian J Exp Biol. 2005 Dec;43(12):1139-43
references.pmid: 16359124
references.citation: Thorax. 2008 Oct;63(10):916-24
references.pmid: 18559366
references.citation: Pharmacol Rev. 2004 Dec;56(4):515-48
references.pmid: 15602009
references.citation: Expert Opin Ther Targets. 2010 Mar;14(3):329-46
references.pmid: 20148719
references.citation: Toxicology. 2002 Jun 14;175(1-3):235-45
references.pmid: 12049851